PAPAVERINE HYDROCHLORIDE

PAPAVERINE HYDROCHLORIDE was reported 102 times

PAPAVERINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TENONECTOMY 1 0.2500
1 UMBILICAL CORD THROMBOSIS 1 0.0556
2 MULTIPLE DRUG THERAPY 13 0.0172
3 ATRIAL PRESSURE INCREASED 1 0.0132
4 CREATININE RENAL CLEARANCE INCREASED 9 0.0120
5 ILIAC ARTERY STENOSIS 1 0.0076
6 PROSTATIC ADENOMA 1 0.0060
7 SEDATION COMPLICATION 15 0.0059
8 PNEUMONITIS ASPIRATION 2 0.0058
9 PEYRONIE'S DISEASE 1 0.0055
10 CREATININE RENAL CLEARANCE DECREASED 15 0.0037
11 RENAL FUNCTION TEST ABNORMAL 13 0.0028
12 MECHANICAL ILEUS 1 0.0018
13 MITRAL VALVE CALCIFICATION 1 0.0016
14 POST PROCEDURAL SEPSIS 1 0.0015
15 AORTIC VALVE SCLEROSIS 1 0.0014
16 BLOOD CALCIUM DECREASED 15 0.0013
17 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
18 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
19 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
20 HALO VISION 1 0.0009
21 PRIAPISM 3 0.0009
22 ACUTE PRERENAL FAILURE 1 0.0009
23 ORTHOSTATIC HYPOTENSION 15 0.0009
24 INCISION SITE PAIN 1 0.0009
25 LEFT ATRIAL DILATATION 1 0.0008
26 ACROCHORDON 1 0.0008
27 RHONCHI 1 0.0007
28 CONJUNCTIVITIS ALLERGIC 1 0.0007
29 BLOOD PRESSURE IMMEASURABLE 1 0.0007
30 INTERMITTENT CLAUDICATION 1 0.0006
31 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
32 CRYPTOCOCCOSIS 1 0.0006
33 COLONIC POLYP 1 0.0006
34 SEDATION 15 0.0006
35 NASAL OEDEMA 1 0.0006
36 IMMUNE-MEDIATED LUNG DISEASE 1 0.0005
37 ESSENTIAL HYPERTENSION 1 0.0005
38 HYPERTENSIVE HEART DISEASE 1 0.0005
39 HYPOPROTEINAEMIA 1 0.0005
40 HYPERAEMIA 1 0.0005
41 MICROCYTIC ANAEMIA 1 0.0005
42 SUBILEUS 1 0.0005
43 EXOPHTHALMOS 1 0.0005
44 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
45 BILIRUBIN CONJUGATED INCREASED 1 0.0004
46 DIABETES INSIPIDUS 1 0.0004
47 DERMAL CYST 1 0.0004
48 GASTROINTESTINAL TUBE INSERTION 1 0.0004
49 TACHYARRHYTHMIA 1 0.0004
50 VENTRICULAR HYPERTROPHY 1 0.0004
51 EXCORIATION 1 0.0004
52 VENTRICULAR DYSFUNCTION 1 0.0004
53 HEPATITIS TOXIC 1 0.0004
54 COMPARTMENT SYNDROME 1 0.0004
55 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
56 TENOSYNOVITIS 1 0.0004
57 METABOLIC ENCEPHALOPATHY 1 0.0003
58 CENTRAL VENOUS CATHETERISATION 1 0.0003
59 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
60 COGNITIVE DISORDER 15 0.0003
61 BLADDER DISORDER 3 0.0003
62 BLOOD UREA INCREASED 5 0.0003
63 NEUTROPHIL COUNT INCREASED 3 0.0003
64 CAROTID ARTERY STENOSIS 1 0.0003
65 DEMENTIA 8 0.0003
66 DIVERTICULUM 2 0.0003
67 MITRAL VALVE INCOMPETENCE 3 0.0003
68 PROSTATOMEGALY 1 0.0003
69 TRICUSPID VALVE INCOMPETENCE 2 0.0003
70 PERIPHERAL ISCHAEMIA 1 0.0002
71 SELF-MEDICATION 1 0.0002
72 AORTIC VALVE INCOMPETENCE 1 0.0002
73 ABSCESS LIMB 1 0.0002
74 PURULENT DISCHARGE 1 0.0002
75 ISCHAEMIA 1 0.0002
76 PULSE ABSENT 1 0.0002
77 MOBILITY DECREASED 15 0.0002
78 HYPERNATRAEMIA 1 0.0002
79 PATHOLOGICAL FRACTURE 1 0.0002
80 INCREASED UPPER AIRWAY SECRETION 1 0.0002
81 VARICOSE VEIN 1 0.0002
82 FOETAL DEATH 1 0.0002
83 INTESTINAL ISCHAEMIA 1 0.0002
84 DEAFNESS UNILATERAL 1 0.0002
85 DRUG ABUSE 15 0.0002
86 ANGIOPATHY 1 0.0002
87 CHOLECYSTITIS ACUTE 1 0.0002
88 BALANCE DISORDER 15 0.0002
89 LYMPHOCYTE COUNT DECREASED 3 0.0002
90 PLEURISY 1 0.0002
91 HYPERLIPIDAEMIA 2 0.0002
92 PROTHROMBIN TIME PROLONGED 1 0.0002
93 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
94 GANGRENE 1 0.0002
95 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
96 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
97 DRUG INTERACTION 24 0.0002
98 BRADYCARDIA 8 0.0002
99 TOXICITY TO VARIOUS AGENTS 24 0.0001
100 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
101 HYPERTHERMIA 1 0.0001
102 HYPOALBUMINAEMIA 1 0.0001
103 APNOEA 1 0.0001
104 RHINITIS 1 0.0001
105 CEREBRAL INFARCTION 3 0.0001
106 DECUBITUS ULCER 1 0.0001
107 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
108 EMBOLISM 1 0.0001
109 SKIN PLAQUE 1 0.0001
110 CARDIAC MURMUR 1 0.0001
111 HYPOTENSION 23 0.0001
112 SPINAL OSTEOARTHRITIS 1 0.0001
113 IRON DEFICIENCY ANAEMIA 1 0.0001
114 DRUG PRESCRIBING ERROR 2 0.0001
115 HYPERCHOLESTEROLAEMIA 1 0.0001
116 OVARIAN CYST 1 0.0001
117 MALNUTRITION 1 0.0001
118 CONSTIPATION 19 0.0001
119 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
120 PHARYNGITIS 1 0.0001
121 PNEUMONIA ASPIRATION 2 0.0001
122 PLATELET COUNT INCREASED 1 0.0001
123 JOINT RANGE OF MOTION DECREASED 1 0.0001
124 QUALITY OF LIFE DECREASED 1 0.0001
125 LYMPHOPENIA 1 0.0001
126 DIALYSIS 1 0.0001
127 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
128 CARDIOGENIC SHOCK 1 0.0001
129 MYELODYSPLASTIC SYNDROME 1 0.0001
130 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
131 FLUID OVERLOAD 1 0.0001
132 ECONOMIC PROBLEM 1 0.0001
133 PHARYNGEAL OEDEMA 1 0.0001
134 MUSCULOSKELETAL CHEST PAIN 1 0.0001
135 TENDONITIS 1 0.0001
136 LUNG INFECTION 1 0.0001
137 EJECTION FRACTION DECREASED 1 0.0001
138 COAGULOPATHY 1 0.0001
139 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
140 DRUG ERUPTION 1 0.0001
141 SYNOVITIS 1 0.0001
142 LEUKOCYTOSIS 1 0.0001
143 MIDDLE INSOMNIA 1 0.0001
144 HYPOCALCAEMIA 1 0.0001
145 GASTRIC ULCER 1 0.0001
146 PROTEINURIA 1 0.0001
147 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
148 HAEMORRHOIDS 1 0.0001
149 OVERDOSE 11 0.0001
150 NEUTROPHIL COUNT DECREASED 2 0.0000
151 PERITONITIS 1 0.0000
152 PULMONARY HYPERTENSION 1 0.0000
153 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
154 FAECES DISCOLOURED 1 0.0000
155 BLOOD CREATININE INCREASED 3 0.0000
156 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
157 FALL 15 0.0000
158 HEART RATE IRREGULAR 1 0.0000
159 HYPOKALAEMIA 2 0.0000
160 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
161 PERICARDIAL EFFUSION 1 0.0000
162 DIABETIC KETOACIDOSIS 1 0.0000
163 OEDEMA PERIPHERAL 5 0.0000
164 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
165 LEUKOPENIA 2 0.0000
166 CHEST DISCOMFORT 4 0.0000
167 HAEMOGLOBIN DECREASED 4 0.0000
168 DRUG RESISTANCE 1 0.0000
169 UNRESPONSIVE TO STIMULI 1 0.0000
170 DIPLOPIA 1 0.0000
171 RESPIRATORY TRACT INFECTION 1 0.0000
172 DEAFNESS 1 0.0000
173 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
174 BLOOD BILIRUBIN INCREASED 1 0.0000
175 PALLOR 1 0.0000
176 RESPIRATORY DISTRESS 1 0.0000
177 FEELING COLD 1 0.0000
178 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
179 LETHARGY 2 0.0000
180 PALPITATIONS 4 0.0000
181 ASCITES 1 0.0000
182 PLEURAL EFFUSION 2 0.0000
183 EPILEPSY 1 0.0000
184 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
185 ATRIAL FIBRILLATION 3 0.0000
186 FUNGAL INFECTION 1 0.0000
187 EYE PRURITUS 1 0.0000
188 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
189 GASTRIC DISORDER 1 0.0000
190 ABDOMINAL DISTENSION 3 0.0000
191 LYMPHADENOPATHY 1 0.0000
192 PLATELET COUNT DECREASED 3 0.0000
193 CEREBRAL HAEMORRHAGE 1 0.0000
194 PAIN 17 0.0000
195 DYSURIA 1 0.0000
196 HALLUCINATION 2 0.0000
197 INTESTINAL OBSTRUCTION 1 0.0000
198 DYSPNOEA 15 0.0000
199 CARDIAC ARREST 2 0.0000
200 PULMONARY OEDEMA 1 0.0000
201 NEUTROPENIA 3 0.0000
202 TINNITUS 1 0.0000
203 CARDIAC DISORDER 2 0.0000
204 ARRHYTHMIA 1 0.0000
205 OCULAR HYPERAEMIA 1 0.0000
206 PRODUCTIVE COUGH 1 0.0000
207 RASH ERYTHEMATOUS 1 0.0000
208 HYPOGLYCAEMIA 1 0.0000
209 HEART RATE INCREASED 2 0.0000
210 DRY EYE 1 0.0000
211 AGGRESSION 1 0.0000
212 CELLULITIS 1 0.0000
213 SINUSITIS 2 0.0000
214 DEPRESSED MOOD 1 0.0000
215 DEPENDENCE 1 0.0000
216 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
217 SEPSIS 2 0.0000
218 NECK PAIN 1 0.0000
219 THROMBOCYTOPENIA 2 0.0000
220 MYALGIA 3 0.0000
221 BONE PAIN 1 0.0000
222 CHILLS 2 0.0000
223 SURGERY 1 0.0000
224 WHEEZING 1 0.0000
225 CATARACT 1 0.0000
226 FEELING ABNORMAL 4 0.0000
227 MUSCLE SPASMS 3 0.0000
228 BLOOD GLUCOSE INCREASED 3 0.0000
229 ANAEMIA 3 0.0000
230 SWELLING FACE 1 0.0000
231 FEBRILE NEUTROPENIA 1 0.0000
232 RENAL FAILURE 2 0.0000
233 BLOOD PRESSURE DECREASED 1 0.0000
234 INJECTION SITE REACTION 1 0.0000
235 INJURY 1 0.0000
236 HYPERTENSION 3 0.0000
237 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
238 RESPIRATORY FAILURE 1 0.0000
239 BRONCHITIS 1 0.0000
240 HOT FLUSH 1 0.0000
241 UNEVALUABLE EVENT 1 0.0000
242 OFF LABEL USE 11 0.0000
243 CARDIAC FAILURE 1 0.0000
244 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
245 INFLUENZA LIKE ILLNESS 1 0.0000
246 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
247 RENAL IMPAIRMENT 1 0.0000
248 CEREBROVASCULAR ACCIDENT 2 0.0000
249 URINARY TRACT INFECTION 2 0.0000
250 MYOCARDIAL INFARCTION 2 0.0000
251 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
252 TACHYCARDIA 1 0.0000
253 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
254 OROPHARYNGEAL PAIN 1 0.0000
255 CHEST PAIN 2 0.0000
256 COUGH 3 0.0000
257 ASTHENIA 4 0.0000
258 SYNCOPE 1 0.0000
259 ERYTHEMA 2 0.0000
260 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
261 MUSCULAR WEAKNESS 1 0.0000
262 DECREASED APPETITE 2 0.0000
263 BACK PAIN 2 0.0000
264 ABDOMINAL PAIN 2 0.0000
265 VISUAL IMPAIRMENT 1 0.0000
266 DIZZINESS 4 0.0000
267 LOSS OF CONSCIOUSNESS 1 0.0000
268 DRUG INEFFECTIVE 10 0.0000
269 PRODUCT QUALITY ISSUE 1 0.0000
270 MEMORY IMPAIRMENT 1 0.0000
271 ANXIETY 2 0.0000
272 RASH 3 0.0000
273 PAIN IN EXTREMITY 2 0.0000
274 CONDITION AGGRAVATED 2 0.0000
275 BLOOD PRESSURE INCREASED 1 0.0000
276 VOMITING 3 0.0000
277 PARAESTHESIA 1 0.0000
278 DIARRHOEA 4 0.0000
279 PNEUMONIA 2 0.0000
280 TREMOR 1 0.0000
281 ABDOMINAL DISCOMFORT 1 0.0000
282 PYREXIA 2 0.0000
283 COVID-19 1 0.0000
284 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
285 PRURITUS 2 0.0000
286 SOMNOLENCE 1 0.0000
287 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
288 ARTHRALGIA 2 0.0000
289 DEPRESSION 1 0.0000
290 INSOMNIA 1 0.0000
291 FATIGUE 2 0.0000
292 DEATH 2 0.0000
293 MALAISE 1 0.0000
294 HEADACHE 1 0.0000
295 NAUSEA 1 0.0000